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Abstract:   
Epstein-Barr virus (EBV) is one of the most common viral infections in humans and persists  
within its host for life. EBV therefore represents an extremely successful virus that has  
evolved complex strategies to evade the host’s innate and adaptive immune response during  
both initial and persistent stages of infection. Here, we conducted a comparative genomics  
analysis on 223 whole genome sequences of world-wide EBV strains. We recover extensive  
genome-wide linkage disequilibrium (LD) despite pervasive genetic recombination. This  
pattern is explained by the global EBV population being subdivided into three main sub- 
populations, one primarily found in East Asia, one in Southeast Asia and Oceania, and the  
third including most of the other globally distributed genomes we analyzed. Additionally, sites  
in LD were overrepresented in immunogenic genes. Taken together, our results suggest that  
host immune selection and local adaptation to different human host populations has shaped  
the genome-wide patterns of genetic diversity in EBV.   
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Introduction:  
  
Epstein-Barr virus (EBV) is a member of the gamma-herpesviruses family, present in most  
humans worldwide. Primary infection is either symptomless or causes infectious  
mononucleosis (IM), and is followed by lifelong latent infection within the memory B cell pool.  
EBV has been associated with a variety of cancerous diseases of B cell origin, such as  
endemic Burkitt’s lymphoma (BL), Hodgkin’s lymphoma (HL) and post-transplant  
lymphoproliferative disorder (PTLD), cancers of epithelial origin including nasopharyngeal  
carcinoma (NPC) and gastric carcinoma and even in rare cases NK- and T-cell tumours  
(Young et al. 2016). Recent evidence also points towards an involvement in autoimmune  
diseases such as multiple sclerosis and systemic lupus erythematosus (Lossius et al. 2012;  
Pender and Burrows 2014). Development of disease is associated with various factors, such  
as immune status (e.g. PTLD, HIV-related lymphoma), co-infections (e.g. endemic BL and  
Malaria, HL and HIV) and geography with EBV-positive NPC particularly prevalent in adults  
from Southern China and Northern Africa, and endemic BL in children from equatorial Africa.  
  
The double-stranded DNA genome of EBV has a length of around 172 kb and contains at  
least 94 annotated open reading frames (ORF). It usually resides as a circular, double- 
stranded DNA molecule in the nucleus. Previous whole genome sequencing analyses have  
focused on geographically related strains and provided evidence for extensive recombination  
(Kwok et al. 2014; Palser et al. 2015). Palser et al. (2015) reported two cases of inter-typic  
recombinants, but also presented evidence for multiple recombination events throughout the  
genome. This latter observation crucially impacts how EBV ancestry can be studied as  
recombination events are expected to affect tree topology and can render inference derived  
from phylogenetic approaches largely meaningless (Rieux and Balloux 2016).  
  
Because pervasive recombination in EBV prevents us from inferring a single, genome-wide  
evolutionary history, we dissected the population structure of EBV genomes at the level of  
single nucleotides or genes. We adapted and applied a recently developed approach  
(Lassalle et al. 2016) based on genome-wide patterns of linkage disequilibrium to a dataset  
comprising 223 EBV genomes collected from all around the world. Specifically, our analysis  
focuses on how sequence variation, recombination and linkage have shaped the global  
population structure of EBV and may have influenced its evolution.   
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Results  
  
EBV genome sequences are highly recombinant   
We utilised a dataset comprising 223 type 1 EBV whole genome sequences that have  
previously been published (de Jesus 2003; Zeng et al. 2005; Liu et al. 2011; Kwok et al.  
2012; Lin et al. 2012 Nov 14; Lei et al. 2013; Tsai et al. 2013; Kwok et al. 2014; Palser et al.  
2015; Chen et al. 2018; Hui et al. 2018; Correia et al. 2018; Bridges et al. 2019). These  
samples are representative of diverse geographical regions, body compartments, and  
malignancies (suppl. table 1).   
  
We first examined our dataset for evidence of recombination. A PHI-test (Bruen et al. 2006)  
found global evidence for recombination (p < 0.05) and a genome-wide PHI-profile scan  
revealed areas of significant recombination throughout the genome (suppl. fig. 1). The  
presence of numerous reticulations in a recombination network confirms this (suppl. fig. 2).  
Consequently, genetic recombination cannot be ignored, thus precluding the use of  
phylogenetic inference from whole genome sequences.  
  
Evidence of genome-wide linkage disequilibrium despite widespread recombination  
A useful way to assess recombination on a larger scale is to consider linkage disequilibrium  
(LD), i.e. the correlation between the occurrence of polymorphisms at different loci in the  
genome (Haydon et al. 2004). Two loci are considered to be in LD when they occur together  
more often than would be expected by chance under a uniform distribution of allele  
combinations given their respective frequencies. There are several factors influencing LD,  
including physical proximity, the rate of recombination, natural selection, and population  
structure. For a given recombination rate, the likelihood of a recombination event is inversely  
proportional to the physical distance between a pair of loci, a negative relationship is  
expected between the LD between two bi-allelic sites and the physical distance separating  
them.  
  
Genome-wide LD was assessed for all combinations of bi-allelic sites using Fisher’s Exact  
test (significant if p < 0.05 after Bonferroni correction). Fig. 1A shows a map of LD between  
bi-allelic sites. In total, 253,935 pairs of sites were found to be in LD, which represent 2,752  
individual sites out of the 9,822 bi-allelic sites analysed. There are 242,372 pairs with at least  
one site being located in an open reading frame (ORF) and 165,407 pairs where both sites  
fall within ORFs (2,229 unique sites). Of these, there are 41,587 pairs where allelic variation  
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at both sites is synonymous, 81,582 pairs with at least one nonsynonymous site and 42,238  
pairs where allelic variation at both sites correspond to nonsynonymous changes.  
  
LD was essentially independent of physical distance in the genome between linked sites  
(suppl. fig. 3), i.e. with similar distributions of p-values over many distance classes, although  
proximal sites showed a lower distribution of p-values. The detection of LD throughout the  
genome even when sites are distal (fig. 1A) is somewhat counterintuitive given the evidence  
of pervasive recombination. Focusing on subsets of sites that are in LD with at least one  
other site (all sites in LD, nonsynonymous sites in LD, and synonymous sites in LD),  
recombination networks (suppl. fig. 4) and PHI-test still gave evidence for recombination  
occurring within all subsets (p < 0.05). Fig. 1B shows an association network of sites linked  
with each other. Each site is represented by a circle, while connections are drawn between  
them if they are in LD. We recovered 62 components, i.e. subnetworks in which every pair of  
sites (nodes) is connected by a path. The components consisted of a large network  
comprising the majority of sites (2,501 out of 2,752, fig. 1C), and smaller sets and pairs of  
independently linked SNPs (fig. 1B-C). However, even the largest component displays  
evidence for recombination (suppl. fig. 5). For the subsequent analyses we focussed on the  
largest component of the network, referred to as the major component, to provide a majority,  
non-chimaeric representation of the genome’s linkage structure.  
  
Genome-wide LD can be explained by population structure  
One possible explanation for the pattern of linkage is the influence of population structure  
whereby apparent co-inheritance of bi-allelic sites simply reflects the independent  
segregation of different alleles in isolated populations. We used the program Admixture  
(Alexander et al. 2009) to cluster individuals into populations. We found no evidence for  
genetic subdivision by body compartment and malignancy (results not shown).  
   
Using all bi-allelic sites (fig. 2A), a very striking top-level structure could be uncovered when  
assuming three subpopulations. Almost all sequences originating from Asia and Oceania  
were assigned to two clusters (C2 and C3, dark red and orange), while the majority of  
African, European, North and South American as well as Australian isolates belong to a third  
cluster (C1, blue), suggesting the existence of two separate virus populations in East Asia  
and in the Pacific, as well as a third separate population of viruses spread throughout the  
rest of the world (as represented by the data set). A number of sequences could not be  
unambiguously assigned to a single cluster and are likely of admixed ancestry.  
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Restricting the dataset to all bi-allelic sites in LD (major component) (fig. 2B) did not change  
the proportional assignment of isolates to populations. The same remains true when the  
analysis was restricted to the subset of pairs on nonsynonymous and synonymous sites in  
LD (fig. 2C-D). By contrast, bi-allelic sites not in LD with any other site do not show evidence  
for a clear population structure corresponding to any geographic pattern, as the assignment  
to C3 and C1 is noisy across genomes (fig. 2E), with the exception of three samples from  
Oceania (all from Papua New Guinea). These three sequences are on very long branches in  
the recombination network (suppl. fig. 2) indicating they are very distant from the rest of the  
dataset. The sites responsible for these long branches were probably not detected as being  
in LD due to the low number of sequences in which they occur.   
  
This top-level view does not capture the full complexity of the EBV population structure. We  
inferred that clustering the isolates into 20 subpopulations best describes the data (suppl. fig.  
6). This leads to an increasingly finer structure in each of the geographical groups. There is a  
large overlap in assignment between sequences from Europe and Australia as well as some  
from North America. By contrast, there are a few clusters formed only by African sequences,  
highlighting the subtler differences between genomes from Africa and Europe/Australia.  
Similarly, a finer structure within the Southeast Asian, East Asian and Oceanian sequences  
emerges. For example, there are distinct subpopulations within China and Hong Kong, and  
one subpopulation frequently associated with Japan. While several of these additional  
subpopulations are comprised of unadmixed individuals, a large number of sequences are  
strongly admixed, confirming the persistent signal of recombination even within the subset of  
sites in LD (suppl. fig. 4-5).   
  
The population structure of EBV is linked to immune genes  
Selection acts primarily on polymorphisms resulting in amino acid changes, and selection for  
co-functional substitutions in proteins could explain the observed LD pattern. In this context,  
it is interesting to note that the proportion of nonsynonymous sites in linkage increases with  
the strength of LD (fig. 3A). To determine which genes are preferentially linked to each other,  
the data was restricted to nonsynonymous sites. When examining which genes contained  
sites that are most often found in LD (number of SNPs in LD), the genes in the top 1% of  
gene pairs were BPLF1, BOLF1, BLLF1, EBNA3A-C, EBNA1, BcRF1, and LMP1 (suppl.  
fig. 7). Interestingly, seven of these nine ORFs are known to encode antigens. The other two  
genes (BcRF1 and BPLF1) do not fulfil our conservative criterion of carrying at least two  
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independent records of experimentally confirmed epitopes.   
  
This led us to hypothesise that adaptation to the host immune system and maintenance of a  
variation at a specific subset of sites might have played a role in shaping the global  
population structure of EBV. To test for this, the dataset of genes was divided in two: genes  
that are known to code for immunogenic (IG) proteins and non-immunogenic (NIG), for which  
there is no current record of experimentally confirmed epitopes (table 1). Nonsynonymous  
sites within these ORFs belonging to IG are more often in LD with each other than would be  
expected if a uniform distribution of links across all genes is assumed (p < 2.2e-16, Chi- 
square test), even when excluding links between proximal SNPs (fig. 3B-C). Conversely,  
genes belonging to NIG are less often linked with each other than expected by chance.  
  
As sites are linked with each other across the whole genome, i.e. SNPs (and ORFs) are not  
only linked to one but to several other SNPs (and ORFs), we sought to study this  
interconnectedness with a graph theoretical approach at the level of individual genes. The  
resulting gene network consisted of 74 genes, 32 of them belonging to IG and 41 belonging  
to NIG, respectively. Edges were weighted based on a linkage score. This linkage score was  
significantly higher for edges between genes both belonging to IG (Mann-Whitney, p = 0.005  
for IG-IG vs. NIG-NIG, and p = 3.6e-5 for IG-IG vs. NIG-IG, respectively; suppl. fig. 8).  
Structurally, this network is connected, i.e. any node can be reached by any other node  
through one or more edges (there are no disconnected components). However, structure  
within the network in terms of clustering seems to be low.  
  
Identifying the most important ORFs in a network can be done by ranking nodes based on  
their properties. Eigenvector centrality does this by measuring the influence of a node, i.e. a  
node’s score is higher if it is connected to other high-scoring nodes (fig. 4). Of the top 25  
highest ranked genes, 11 belong to the IG group (table 2). An additional five genes within the  
top 25 also appear in the IEDB database as antigens, but did not meet our conservative  
criterion of a minimum of two independent records as experimentally confirmed antigens. In  
total, 36 of the 94 annotated ORFs in the EBV genome contain experimentally confirmed  
epitopes that fulfil this criterion. Of those, 32 are represented in the linked gene network  
(table 1), and 11/32 IG nodes are within the top 25 highest ranked genes.   
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Discussion  
Recombination plays an important role in viral evolution as a source of genetic diversity. By  
combining mutations that previously appeared separately in different genomes,  
recombination allows the creation of new haplotypes. Genome-wide recombination has been  
described in detail for all well-studied herpesviruses (Norberg et al. 2007; Smith et al. 2013;  
Norberg et al. 2015; Lassalle et al. 2016; Koelle et al. 2017). It has been best studied at the  
molecular level in Herpes simplex virus 1 (HSV-1) where it is part of the replication process  
(Wilkinson and Weller 2003). However, recombination has also been proposed as a  
mechanism for herpesviruses to maintain the integrity of viral genomes during latency  
(Wilkinson and Weller 2004; Brown 2014).   
  
Here we show that despite extensive recombination, EBV retains considerable population  
structure with evidence for extensive genome-wide linkage disequilibrium. These findings  
differ from those observed for Human cytomegalovirus (HCMV) (Lassalle et al. 2016) and  
HSV-1 (Lassalle, Beale et al., unpublished data) both of which appear to be essentially freely  
recombining with only localised areas of linkage disequilibrium. The extent to which free  
recombination can occur in different herpesviruses might be due to their employment of the  
host’s homologous recombination (HR) systems (Brown 2014).   
  
In alpha-herpesviruses such as HSV-1 and Varicella zoster virus, inverted and tandem  
repeats are the most prevalent HR initiating sequences and these are enriched in the unique  
short (US or S) segment of the genome. By contrast, HR initiating sequences in gamma- 
herpesviruses like EBV have been shown to be specific short GC-rich sequences that are  
evenly distributed across the genome (Brown 2014). Additional studies are required to better  
understand these apparent differences in LD and recombination across different herpesvirus  
families. Other potential causes for disparities in the inferred recombination intensity between  
these viral species may be driven by their opportunity to recombine and the distribution of the  
genetic divergence of recombining viral strains.   
  
In the presence of extensive genetic recombination, LD is generally driven by an underlying  
population structure, which in turn might reflect biological or environmental constraints  
(McVean et al. 2002), or genetic drift within geographically segregated populations. In the  
case of EBV, population structure analyses identified a complex structure which largely  
corresponds on the top-level to three geographic groups: East Asia, Oceania (represented by  
Papua New Guinea) & Southeast Asia (represented by Indonesia), and the rest of the world.  
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This structure is primarily supported by the sites in LD, with the exception of three very  
divergent sequences from Oceania (suppl. fig. 2) for which there is a signal of structure even  
in the set of SNPs not in LD. On a finer scale, EBV population structure is naturally more  
complex. In our analysis, we found 20 subpopulations to best describe our data. Similarly, a  
previous study with a smaller, partly different data set (including Mediterranean and type 2  
sequences) described ten subpopulations (Chiara et al. 2016). Both works show a correlation  
between geography and subpopulation, in particular with distinct subpopulations present in  
Africa, as well as overlapping subpopulations across the world, e.g. Europe/Australia and  
America/Africa. However, our study also highlights the presence of distinct subpopulations  
within Asia (and Oceania), which was previously not described.   
  
Our data confirm previous findings where Asian and Indonesian sequences cluster quite  
distinctly from other genomes in a PCA (Palser et al. 2015; Correia et al. 2018). A few  
samples have been assigned to different clusters than the majority of genomes from the  
same region. For example, one genome from Hong Kong and one genome from Indonesia  
have been completely assigned to C1 (associated with non-Asian and non-Oceanian  
sequences). Similarly, four sequences from Indonesia, one sequence each from the US and  
from Brazil, as well as five UK sequences seem to belong to C2 (associated with East-Asia).  
However, the geographic label of the sequences is based on where they have been isolated  
and does not necessarily reflect the actual evolutionary origin of the virus genotype. There  
are only a handful of sequences isolated in the UK, for which the geographic origin of the  
donor is given (mentioned in brackets in fig. 2 and suppl. table 1) and where the assignment  
to different clusters than C1 is traceable. It is easily imaginable that a sequence isolated in  
the UK or the US, countries with mixed ethnic populations, could originally be an Asian  
strain, as primary infection often occurs through close family members in early age (Hjalgrim  
et al. 2007).  
  
Recombination is also occurring within these subpopulations, with evidence for  
recombination within the subset of sites in LD (PHI-test, p < 0.05). Within-population  
recombination is also supported by the presence of admixed individuals in the population  
structure assignment, both for the top-level structure as well as the fine-resolution population  
structure analysis into 20 subpopulations (suppl. fig. 7). HKNPC2, for example, has been  
described as recombinant of HKNPC7 and -9 (Kwok et al. 2014), all isolates from Hong Kong  
that have been clearly assigned to the East Asian population (Palser et al. 2015).  
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In contrast to other herpesviruses, and despite this ever-present signal of recombination  
between and within subpopulations, EBV largely maintains its population structure.  
Interestingly, the proportion of nonsynonymous sites increases with the strength of LD (fig.  
3A). This finding suggests that the pattern of genetic linkage is driven by natural selection on  
encoded proteins, notably preserving combination of residues determining how proteins  
functionally interact with each other. This hypothesis is compatible with the correlation of  
higher strength of LD with the increase in fraction of non-synonymous bi-allelic sites and  
could indicate that synonymous sites are less likely to be constrained to co-evolve; instead,  
the existence of stronger LD within the 2-kb range (suppl. fig. 3) suggests that synonymous  
sites may be hitch-hiking with physically linked sites, i.e. only contingently segregating with  
closely located non-synonymous sites under selection.  
  
The association of linked polymorphism distribution with geography or ethnicity might reflect  
different biological constraints in each viral subpopulation. We thus investigated the  
possibility that important protein-protein interactions (PPI) could be determining EBV  
population structure. By representing the genes with the strongest LD in a linked gene  
network (fig. 4), we were able to identify the 25 most important nodes via an Eigenvector  
centrality-based ranking and compare them with data on PPIs previously described for EBV  
(Calderwood et al. 2007; Fossum et al. 2009) (suppl. fig. 9). While a few recovered  
interactions relate to known interactions (e.g. interaction between tegument and envelope  
proteins BPLF1, BALF4 and BOLF1), no straightforward hypothesis of biological cause can  
be proposed for others, due to their primary expression occurring in different stages of the  
life cycle as well as the current evidence for their localisation within the cell or virion, for  
example between the proteins encoded by BDLF3 (a glycoprotein expressed late in lytic  
cycle) and EBNA3A (which is located in the nucleus and expressed during latency).  
Nevertheless, PPI might explain some of the sites in LD observed in non-immunogenic  
genes.  
  
Since PPI data based on yeast two hybrid screen is known to have a high false positive rate  
(Deane et al. 2002), we looked for other explanations for gene associations and considered a  
possible role of variation in host genetic makeup. Host genetics has been previously  
suggested to shape pathogen population structure, for example in HIV (Kløverpris et al.  
2016), Mycobacterium tuberculosis (Gagneux et al. 2006; Gagneux 2012) or Helicobacter  
pylori (Thorell et al. 2017). However, it is challenging to disentangle the effect of the  
demography of the pathogen and its host(s) from local adaption of a pathogen to its different  
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host populations and their wider environment. It is probably fair to state that so far there is no  
case where host genetics could be uncontroversially identified as the driver for the  
apportionment of genetic diversity in a pathogen. Moreover, none of the previous putative  
cases of within-species host adaptations invoked selective pressures at such a large number  
of variants spread throughout the genome of a pathogen. Our results on EBV are also to the  
best of our knowledge the first case of such widespread gene-by-gene epistasis.  
  
In EBV, the number of LD links between genes encoding proteins that are targets of adaptive  
immunity was significantly higher than between proteins with no adaptive immune function  
(fig. 3B-C). Moreover, 11 out of the 25 most important linked genes code for protein  
sequences that are the target of adaptive immunity. However, some of the genes we classify  
as non-immunogenic might in fact also contain epitopes that have not been described so far.  
The results raise the possibility that the EBV population structure may to a large extent have  
been shaped by host immunity, perhaps because the virus has adapted to HLA alleles  
common in the subpopulation in which it is circulating. The data is in concordance with a  
model of non-overlapping combinations of epitope regions, that are being held in LD despite  
genetic exchange via recombination between pathogens in other parts of the genome (Gupta  
et al. 1996).  
  
In summary, we find that EBV retains a strong population structure in the face of  
considerable recombination and that this population structure is geographically stratified. The  
maintenance of the viral population structure may be partly driven by intrinsic viral co- 
adaptation of genes. Though, the evidence that genes in strongest LD are enriched in  
immunogenic genes suggests that adaptive immune selection, likely HLA mediated, has  
played a significant role in the maintenance of epistasis within this population. This raises the  
intriguing possibility that host genetic factors of the human populations in which the virus  
subpopulations have been circulating have been shaping the global population structure of  
EBV through local adaptation to its local human host populations. Irrespective of the  
underlying evolutionary forces, our findings starkly distinguish EBV from other human  
herpesviruses such as HCMV, which has been shown to be essentially freely recombining  
(Lassalle et al. 2016).   
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Methods  
Dataset  
The dataset consisted of 223 type 1 EBV whole genome sequences available from Genbank  
(suppl. table 1), comprising samples from various geographical regions and malignancies.  
The selection of sequences is explained in the supplementary methods.  
  
Sequence analysis  
Multiple sequence alignments were obtained using mafft v7.407 (Katoh and Standley 2013)  
and manually corrected to reduce unnecessary gaps generated around short tandem repeat  
sequences. SNPs were called based on differences to the reference genome NC_007605  
(B95-8) using the R packages adegenet (Jombart 2008) and ape (Paradis et al. 2004).   
  
Recombination and Linkage Disequilibrium (LD)  
A test for the presence of recombination (PHI-test) was performed on the whole genome  
alignment excluding gapped sites with PhiPack under default parameters (Bruen et al. 2006).  
Additionally, a profile of PHI test p-values was computed along the genomes with sliding  
window of 1,000bp and a step size of 25bp. Split networks were generated using Splitstree4  
(Huson and Bryant 2006).  
  
For the genome wide analysis of linkage, the whole genome alignment of type 1 sequences  
was restricted to its 9,822 bi-allelic sites where maximally five sequence were missing.  
Linkage between all possible combinations of bi-allelic SNPs was tested with Fisher’s Exact  
test, with a pair of SNPs being significantly associated if p < 0.05 after Bonferroni correction.  
Based on all linked sites, an association network was constructed with igraph (Csárdi and  
Nepusz 2006).  
  
Split networks were generated from subsamples of aligned sites: all SNPs, all linked SNPs  
(sites in LD with at least one other site), all linked sites of the biggest component of the  
association network, all nonsynonymous linked SNPs, and all synonymous linked SNPs.  
  
Population structure  
The population structure was analysed with Admixture 1.3.0 (Alexander et al. 2009). It was  
run ten times for every k ranging from 1 to 40 with the cross-validation option to infer the  
number of clusters k that best fits the data. Replicate runs were further processed using  
CLUMPAK (Kopelman et al. 2015) and results for the major modes were visualised with  
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Distruct (Rosenberg 2004).  
  
Gene linkage network  
A network was constructed and analysed with the R package igraph (Csárdi and Nepusz  
2006), where each node represents an ORF. An edge between two nodes was drawn if there  
was at least one pair of nonsynonymous SNPs in LD between them. The edges were  
weighted by a linkage score based on the number of linked nonsynonymous SNPs between  
two ORFs, normalised by the sum of ORF lengths (expressed as a fraction of the genome  
length).   
   
The nodes of the network were divided into two sets of nodes, a) those ORFs known to  
encode antigens (immunogenic, IG) and b) those that do not (non-immunogenic, NIG). This  
classification was based on the experimentally confirmed antigens found in the IEDB  
database (http://www.iedb.org, April 2019)(Vita et al. 2018), with restriction to those antigens  
whose epitopes had been confirmed by at least two studies.  
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Figures 
 
Figure 1: A) Heatmap of SNPs which are in significant LD. Darker colours indicate lower p-
values, with insignificant pairs being colours white. Numbers denote the genome positions 
(sampled uniformly), with rows and columns that did not contain any significant pair of SNPs 
in LD removed. B) Association network of all sites in LD with at least one other site. Each 
node represents a bi-allelic site, each link between two nodes signifies they are in LD with 
each other. C) Frequency plot of all connected components in the associated network.  
 
Figure 2: Population assignment for all genome sequences assuming a population number of 
k = 3 for different subsets of sites. Every bar represents a strain that has been preassigned 
to either "Africa", "Asia" or "Western" (comprised of American, European and Australian 
isolates). The colouring of the bars represents the proportion of the input sites that have 
been assigned to a certain population. A) all bi-allelic sites; B) all sites in LD in the largest 
component; C) nonsynonymous pairs of sites in LD; D) synonymous pairs of sites in LD; E) 
sites not in LD. B-D refer to the subset of sites in LD that are in the largest component in the 
association network (figure 1B). 
 
Figure 3: A) Proportion of pairs of nonsynonymous sites in LD with each other over LD 
strength. B-C) Number of links between nonsynonymous sites between different categories 
of genes. B) All sites (Chi-square test, p < 2.2e-16). C) Sites with a minimal distance of 1 kb 
(Chi-square test, p < 2.2e-16). 
 
Figure 4: Whole gene network, coloured based on Eigenvector centrality, with warm colours 
indicating higher and cooler colours lower scores, respectively. Square node symbols denote 
genes belonging to IG, circular nodes denote genes belonging to NIG.  
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Tables 
 
Table 1: List of 32 genes present in the gene network considered to code for immunogenic 
proteins. Each epitope must have at least two references listed in IEDB.  
Protein ORF number of 
epitopes 
Major DNA-binding protein BALF2 2 
Tripartite terminase subunit UL28 homolog BALF3 1 
Envelope glycoprotein B BALF4 16 
DNA polymerase catalytic subunit BALF5 1 
Ribonucleoside-diphosphate reductase small chain BaRF1 1 
Portal protein UL6 homolog BBRF1 1 
Major capsid protein BcLF1 3 
Triplex capsid protein VP23 homolog BDLF1 1 
Capsid protein VP26 BFRF3 13 
Protein BGLF3 BGLF3 1 
Apoptosis regulator BHRF1 BHRF1 3 
Envelope glycoprotein GP350 BLLF1 2 
Deoxyuridine 5'-triphosphate nucleotidohydrolase BLLF3 3 
DNA polymerase processivity factor BMRF1 BMRF1 8 
Protein BMRF2 BMRF2 1 
Major tegument protein BNRF1 4 
Protein BOLF1 BOLF1 2 
Ribonucleoside-diphosphate reductase large 
subunit 
BORF2 1 
Replication and transcription activator BRLF1 8 
Tegument protein BRRF2 BRRF2 2 
DNA primase BSLF1 1 
Envelope glycoprotein H BXLF2 11 
Trans-activator protein BZLF1 BZLF1 24 
Epstein-Barr nuclear antigen 1 EBNA1 82 
Epstein-Barr nuclear antigen 2 EBNA2 12 
Epstein-Barr nuclear antigen 3 EBNA3A 30 
Epstein-Barr nuclear antigen 4 EBNA3B 23 
Epstein-Barr nuclear antigen 6 EBNA3C 33 
Protein LF2 LF2 1 
Uncharacterised protein LF3 LF3 1 
Latent membrane protein 1 LMP1 17 
Latent membrane protein 2 LMP2 32 
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Table 2: Most influential nodes in the network.   
Eigenvector rank ORF Protein IG 
1  BPLF1 Large tegument protein deneddylase  ○ 
2  BcRF1 TBP-like protein   
3  BBLF4 DNA replication helicase   
4  EBNA3B Epstein-Barr nuclear antigen 4  ● 
5  BLLF1 Envelope glycoprotein GP350 ● 
6  BNRF1 Major tegument protein  ● 
7  EBNA1 Epstein-Barr nuclear antigen 1  ● 
8  BALF3 Tripartite terminase subunit 1  
9  BGLF1 Capsid vertex component 1 ○ 
10  BKRF4 Tegument protein   
11  EBNA3A Epstein-Barr nuclear antigen 3  ● 
12  LMP1 Latent membrane protein 1  ● 
13  EBNA3C Epstein-Barr nuclear antigen 6  ● 
14  BOLF1 Protein BOLF1  ● 
15  BRRF2 Tegument protein  ○ 
16  BALF2 Major DNA-binding protein  
17  BDLF3 BDLF3 (Glycoprotein)   
18  BSLF1 DNA primase  
19  BVRF1 Capsid vertex component 2 ○ 
20  BRLF1 Replication and transcription activator ● 
21  BXLF2 Envelope glycoprotein H  ● 
22  BDLF4 Uncharacterised protein  
23  LF1 Uncharacterised protein  
24  BBLF2-BBLF3 
DNA helicase/primase complex-
associated protein ○ 
25  BALF4 Envelope glycoprotein B  ● 
Circles in the column labelled IG mark proteins for which an immune response has been  
reported, with filled circles fulfilling the criterium of having at least two references and  
empty circles having fewer than two.   
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